Protalix Biotherapeutics PLX 深 沪
等待开盘 08-26 09:30:00 美东时间
1.60
-0.060
-3.61%
华盛通- 最 高1.655
- 今 开1.64
- 成交量 52.19万股
- 最 低 1.59
- 昨 收 1.66
- 总市值 1.27亿
- 52周最高 3.10
- 市盈率 静 43.72
- 换手率 0.66%
- 52周最低 0.96
- 委 比 -3.70%
- 总股本 7960.71万
- 历史最高 77.00
- 量 比 1.04
- 振 幅 3.92%
- 历史最低 0.70
- 每 手 1
- 风险率 0.57%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Protalix BioTherapeutics Q2 Sales $15.658M Beat $13.546M Estimate
Protalix BioTherapeutics (AMEX:PLX) reported quarterly sales of $15.658 million which beat the analyst consensus estimate of $13.546 million by 15.59 percent. This is a 16.21 percent increase over sales of $13.474
08-14 18:51
Earnings Scheduled For August 14, 2025
Companies Reporting Before The Bell • Sunlands Technology (NYSE:STG) is likely ...
08-14 16:32
Protalix BioTherapeutics Q2 Earnings Preview
Protalix BioTherapeutics (NYSE:PLX) is scheduled to announce Q2 earnings results on Thursday, August 14th, before market open. The consensus EPS Estimate is $0.03 and the consensus Revenue Estimate is...
08-14 01:11
Protalix Lawsuit Dismissed After Bylaws Amendment
Protalix ( ($PLX) ) has provided an update. On August 1, 2025, Protalix BioTher...
08-02 05:09
美股代币化的流动性思考：链上交易逻辑该如何重建？
文章来源：Odaily星球日报 6 月底以来，Crypto 行业掀起了一场‘美股上链’热潮，Robinhood、Kraken 等相继推出代币化版本的美国...
07-23 10:00
Protalix Appoints New CFO to Boost Growth Strategy
Protalix ( ($PLX) ) has provided an update. On July 21, 2025, Protalix BioThera...
07-21 21:51
Protalix BioTherapeutics appoints Gilad Mamlok as CFO
Protalix BioTherapeutics (NYSE:PLX) Monday announced the appointment of Gilad Mamlok to serve as the company's new Senior Vice President and Chief Financial Officer, effective August 24, succeeding Ey...
07-21 19:00
PLUXEE N.V. (PLX) Receives a Buy from Kepler Capital
In a report released on July 2, Julien Richer from Kepler Capital maintained a ...
07-04 09:36
Protalix BioTherapeutics Added to Russell 3000® and 2000 Indexes®
CARMIEL, Israel, June 30, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization o...
06-30 18:50
Protalix BioTherapeutics shares are trading lower after the company reported worse-than-expected Q1 financial results.
Protalix BioTherapeutics shares are trading lower after the company reported wo...
05-09 20:45
